Quteba Ebrahem

2.1k citations

31 papers · 1.5k indexed · 1 hit paper · h-index 18

Impact in

Ophthalmology top 2%
- Retinal Diseases and Treatments
Cancer Research top 5%
- Protease and Inhibitor Mechanisms

Papers in

Hematology 15
- Acute Myeloid Leukemia Research 11
- Blood Coagulation and Thrombosis Mechanisms 4
Ophthalmology 9
- Retinal Diseases and Treatments 8
- Glaucoma and retinal disorders 4

Co-authors: Bela Anand‐Apte Jian Qi Gillian Murphy Andrew H. Baker Mark Bond Nina Z. Moore Lena Claesson‐Welsh Jonathan E. Sears
Journals: Blood (5 papers)Investigative Ophthalmology & Visual Science (3 papers)Advances in experimental medicine and biology (2 papers)The Anatomical Record (2 papers)Journal of Biological Chemistry (2 papers)
Partner nations: United States United Kingdom China

In The Last Decade

Quteba Ebrahem

30 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 2003 · 520 citations

Peers

Countries citing papers authored by Quteba Ebrahem

Since Specialization

Citations

This map shows the geographic impact of Quteba Ebrahem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quteba Ebrahem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quteba Ebrahem more than expected).

Fields of papers citing papers by Quteba Ebrahem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quteba Ebrahem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quteba Ebrahem. The network helps show where Quteba Ebrahem may publish in the future.

Co-authors

The 25 scholars most cited alongside Quteba Ebrahem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Quteba Ebrahem Line = papers co-authored together Quteba Ebrahem links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Tracking Decitabine Incorporation into Malignant Myeloid Cell DNA in vitro and in vivo by LC-MS/MS with Enzymatic Digestion Scientific Reports ·Mahmoud Mohammad Muqat, Ye Feng, Lan Li, Reda Z. Mahfouz, Quteba Ebrahem, Yogen Saunthararajah, Yan Xu	2019	9
2	Mechanisms of Resistance to 5-Azacytidine/Decitabine in MDS-AML and Pre-Clinical In Vivo Proof of Principle of Rational Solutions to Extend Response Blood ·Quteba Ebrahem, Reda Z. Mahfouz, Lisa Durkin, Mikkael A. Sekeres, Anjali S. Advani, Hetty E. Carraway, Sudipto Mukherjee, Betty K. Hamilton, Aaron T. Gerds, Ronald Sobecks, Frederic J. Reu, Eric D. Hsi, Jaroslaw P. Maciejewski, I. Wundermann	2015	6
3	Runx1 Regulation of Pu.1 Corepressor/Coactivator Exchange Identifies Specific Molecular Targets for Leukemia Differentiation Therapy Journal of Biological Chemistry ·Xiaorong Gu, Zhenbo Hu, Quteba Ebrahem, John S. Crabb, Reda Z. Mahfouz, Tomas Radivoyevitch, John W. Crabb, Yogen Saunthararajah	2014	26
4	Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine Therapy Clinical Cancer Research ·Reda Z. Mahfouz, Ania Jankowska, Quteba Ebrahem, Xiaorong Gu, Valeria Visconte, Ali Tabarroki, Pramod Terse, Joseph M. Covey, Kenneth K. Chan, Yonghua Ling, Kory J. Engelke, Mikkael A. Sekeres, Ramón V. Tiu, Jaroslaw P. Maciejewski, Tomas Radivoyevitch, Yogen Saunthararajah	2013	105
5	Runx1 deficiency permits granulocyte lineage commitment but impairs subsequent maturation Oncogenesis ·Kwok Peng Ng, Zhenbo Hu, Quteba Ebrahem, Soledad Negrotto, Jörn Lausen, Yogen Saunthararajah	2013	12
6	Tissue Inhibitor of Metalloproteinases-3 Peptides Inhibit Angiogenesis and Choroidal Neovascularization in Mice PLoS ONE ·Jian Qi, Quteba Ebrahem, L. Kreidberg, Alecia Cutler, Brent A. Bell, Camilo Calderón Nova, Jonathan E. Sears, Vera Knäuper, Gillian Murphy, Bela Anand‐Apte	2013	31
7	Altered Angiogenesis in Caveolin-1 Gene–Deficient Mice Is Restored by Ablation of Endothelial Nitric Oxide Synthase American Journal Of Pathology ·Christudas Morais, Quteba Ebrahem, Bela Anand‐Apte, Marie‐Odile Parat	2012	30
8	p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia Leukemia ·Kwok Peng Ng, Quteba Ebrahem, Soledad Negrotto, Reda Z. Mahfouz, Kevin A. Link, Zhenbo Hu, Xiaosong Gu, Anjali S. Advani, M Kalaycio, Ronald Sobecks, Mikkael A. Sekeres, Ed Copelan, Tomas Radivoyevitch, Jaroslaw P. Maciejewski, James C. Mulloy, Yogen Saunthararajah	2011	51
9	Decitabine Maintains Hematopoietic Precursor Self-Renewal by Preventing Repression of Stem Cell Genes by a Differentiation-Inducing Stimulus Molecular Cancer Therapeutics ·Zhenbo Hu, Soledad Negrotto, Xiaorong Gu, Reda Z. Mahfouz, Kwok Peng Ng, Quteba Ebrahem, Edward A. Copelan, Harinder Singh, Jaroslaw P. Maciejewski, Yogen Saunthararajah	2010	40
10	Betacellulin Induces Increased Retinal Vascular Permeability in Mice PLoS ONE ·Bela Anand‐Apte, Quteba Ebrahem, Alecia Cutler, BK Kundu, Masahiko Sugimoto, Joe G. Hollyfield, Judah Folkman	2010	25
11	VESGEN 2D: Automated, User‐Interactive Software for Quantification and Mapping of Angiogenic and Lymphangiogenic Trees and Networks The Anatomical Record ·世昭劉, Patricia Keith, 在坤柳, Mita Maya Meysyanti, Michiko Watanabe, Monica M. Montano, Ganga Karunamuni, Peter K. Kaiser, Jonathan E. Sears, Quteba Ebrahem, Yuchen Liang, 陈言, Patricia Parsons‐Wingerter	2009	55
12	Cross-Talk between Vascular Endothelial Growth Factor and Matrix Metalloproteinases in the Induction of Neovascularization in Vivo American Journal Of Pathology ·Quteba Ebrahem, Shyam S. Chaurasia, Amit Vasanji, Jian Qi, А.Р. Аблаев, Alecia Cutler, Kewal Asosingh, Serpil C. Erzurum, Bela Anand‐Apte	2009	96
13	VESGEN 2D: Automated, User‐Interactive Software for Quantification and Mapping of Angiogenic and Lymphangiogenic Trees and Networks The Anatomical Record ·世昭劉, Patricia Keith, 在坤柳, Mita Maya Meysyanti, Michiko Watanabe, Monica M. Montano, Ganga Karunamuni, Peter K. Kaiser, Jonathan E. Sears, Quteba Ebrahem, Yuchen Liang, 陈言, Patricia Parsons‐Wingerter	2009	3
14	Betacellulin Induces Increased Retinal Vascular Permeability in Proliferative Diabetic Retinopathy Investigative Ophthalmology & Visual Science ·Bela Anand‐Apte, Quteba Ebrahem, Alicia A. Cutler, Joe G. Hollyfield, Judah Folkman	2008	1
15	Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy Proceedings of the National Academy of Sciences ·Jonathan E. Sears, George Hoppe, Quteba Ebrahem, Bela Anand‐Apte	2008	94
16	Carboxyethylpyrrole Adducts, Age-related Macular Degeneration and Neovascularization Advances in experimental medicine and biology ·Kutralanathan Renganathan, Quteba Ebrahem, Amit Vasanji, Xiaorong Gu, Lu Liang, Jonathan E. Sears, Robert G. Salomon, Bela Anand‐Apte, John W. Crabb	2007	11
17	Triamcinolone Acetonide Inhibits IL-6– and VEGF-Induced Angiogenesis Downstream of the IL-6 and VEGF Receptors Investigative Ophthalmology & Visual Science ·Quteba Ebrahem, Atsushi Minamoto, George Hoppe, Bela Anand‐Apte, Jonathan E. Sears	2006	58
18	Tissue Inhibitor of Metalloproteinases-3 and Sorsby Fundus Dystrophy Advances in experimental medicine and biology ·Jian Qi, Quteba Ebrahem, Bela Anand‐Apte	2003	6
19	A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 Nature Medicine ·Jian Qi, Quteba Ebrahem, Nina Z. Moore, Gillian Murphy, Lena Claesson‐Welsh, Mark Bond, Andrew H. Baker, Bela Anand‐Apte Hit paper breakdown →	2003	520
20	Expression of Sorsby's Fundus Dystrophy Mutations in Human Retinal Pigment Epithelial Cells Reduces Matrix Metalloproteinase Inhibition and May Promote Angiogenesis Journal of Biological Chemistry ·Jian Qi, Quteba Ebrahem, Karen Yeow, Dylan R. Edwards, Paul L. Fox, Bela Anand‐Apte	2002	45

About Quteba Ebrahem

Quteba Ebrahem is a scholar working on Hematology, Ophthalmology, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Retinal Diseases and Treatments (8 papers), Epigenetics and DNA Methylation (7 papers), Protease and Inhibitor Mechanisms (6 papers), Glaucoma and retinal disorders (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Retinal Imaging and Analysis (3 papers). The work is most often cited by research in Ophthalmology (289 citations), Cancer Research (408 citations), Hematology (244 citations), Immunology and Allergy (78 citations) and Molecular Biology (808 citations). Quteba Ebrahem has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Bela Anand‐Apte, Jian Qi, Gillian Murphy, Andrew H. Baker, Mark Bond, Nina Z. Moore, Lena Claesson‐Welsh, Jonathan E. Sears, Yogen Saunthararajah and Reda Z. Mahfouz. Their work appears in journals such as Blood, Investigative Ophthalmology & Visual Science, Advances in experimental medicine and biology, The Anatomical Record and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact